Wilate (von Willebrand factor/coagulation factor VIII complex [human]) – Expanded indication
December 1, 2023 - The FDA approved Octapharma’s Wilate (von Willebrand factor/coagulation factor VIII complex [human]), in children and adults with von Willebrand disease for routine prophylaxis to reduce the frequency of bleeding episodes.
Top